U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Funding > Funding Newsletter for Global Health Researchers > Funding news for global health researchers October 4, 2021 Print

COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

Funding news for global health researchers October 5, 2021

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Top NIH Funding News

Important news from NIH for all grantees.

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

  • Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R01 - Clinical Trial Optional) (PAR-21-344)
    Application Receipt Dates: Multiple dates, see announcement.
    Note: Fogarty is the leading IC for this funding opportunity.

NIH funding opportunities for which foreign organizations may apply.

  • The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional) (PAR-21-348)
    Application Receipt Dates: Multiple dates, see announcement.
  • Role of Astrocytes in Degeneration of the Neurovascular Unit in Alzheimer’s disease (AD)/AD-related dementias (ADRDs) (R01 Clinical Trial Not Allowed) (PAR-22-037)
    Application Receipt Date: February 4, 2022
  • Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed) (RFA-AI-21-065)
    Application Receipt Date: January 14, 2022

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers.

  • NOSI: Notice of Special Interest: Resilience and Vulnerability following Acute Heart, Lung, Blood, and Sleep Insults in People with HIV (R01, Clinical Trial Not Allowed) (NOT-HL-22-002)
  • Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders (NOT-NS-22-010)

Upcoming Deadlines